<!DOCTYPE HTML>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Comorbidities of Rheuma endpoints</title>
</head>
<body>
<br>
<div><a href="taglist.html">Back to all tags listing
</a>
</div>
<h1>#RHEUMA_CM: Comorbidities of Rheuma endpoints</h1>
<span style="margin-left:1em; font-size:130%;"><a href="I9_ISCHHEART.html">[2] I9_ISCHHEART</a>: Ischemic heart diseases (ICD-10: I2[0-5]|T822|Z951)<br></span>
<span style="margin-left:2em;"><a href="I9_ANGINA.html">[3] I9_ANGINA</a>: Angina pectoris (ICD-10: I20)<br></span>
<span style="margin-left:2em;"><a href="I9_MI.html">[3] I9_MI</a>: Myocardial infarction (ICD-10: I2[1-2])<br></span>
<span style="margin-left:2em;"><a href="I9_MI_STRICT.html">[3] I9_MI_STRICT</a>: Myocardial infarction, strict (ICD-10: I2[1-2])<br></span>
<span style="margin-left:2em;"><a href="I9_MI_COMPLICATIONS.html">[3] I9_MI_COMPLICATIONS</a>: Complications following myocardial infarction (ICD-10: I23)<br></span>
<span style="margin-left:2em;"><a href="I9_POSTAMI.html">[3] I9_POSTAMI</a>: Status post-ami (ICD-10: I253)<br></span>
<span style="margin-left:2em;"><a href="I9_CORATHER.html">[3] I9_CORATHER</a>: Coronary atherosclerosis (ICD-10: I2[4-5]|T822|Z951)<br></span>
<span style="margin-left:0em;"><a href="I9_REVASC.html">[C] I9_REVASC</a>: Coronary revascularization (ANGIO or CABG) <br></span>
<span style="margin-left:2em;"><a href="I9_ANGIO.html">[3] I9_ANGIO</a>: Coronary angiopasty <br></span>
<span style="margin-left:2em;"><a href="I9_CABG.html">[3] I9_CABG</a>: Coronary artery bypass grafting <br></span>
<span style="margin-left:0em;"><a href="E4_OBESITY.html">[C] E4_OBESITY</a>: Obesity (ICD-10: E66)<br></span>
<span style="margin-left:0em;"><a href="I9_REVASC.html">[C] I9_REVASC</a>: Coronary revascularization (ANGIO or CABG) <br></span>
<span style="margin-left:0em;"><a href="I9_INTRACRA.html">[C] I9_INTRACRA</a>: Nontraumatic intracranial haemmorrhage (ICD-10: I6[0-1])<br></span>
<span style="margin-left:0em;"><a href="I9_STR.html">[C] I9_STR</a>: Stroke, excluding SAH (ICD-10: I6[13-4])<br></span>
<span style="margin-left:0em;"><a href="I9_STR_SAH.html">[C] I9_STR_SAH</a>: Stroke, including SAH (ICD-10: I6[0-13-4])<br></span>
<span style="margin-left:0em;"><a href="E4_DM2.html">[C] E4_DM2</a>: Type 2 diabetes (ICD-10: E11)<br></span>
<span style="margin-left:0em;"><a href="E4_DM2_STRICT.html">[C] E4_DM2_STRICT</a>: Type 2 diabetes, strict (exclude DM1) (ICD-10: E11)<br></span>
<span style="margin-left:0em;"><a href="K11_IBD.html">[C] K11_IBD</a>: Inflammatory bowel disease (ICD-10: K5[0-1])<br></span>
<span style="margin-left:0em;"><a href="I9_HYPTENS.html">[C] I9_HYPTENS</a>: Hypertension (ICD-10: I1[0-35]|I674)<br></span>
<span style="margin-left:margin-left:0em;;"><a href="C_STROKE.html">C_STROKE</a>: STROKE (ICD-10: G45|I6[0-4])<br></span>
<span style="margin-left:margin-left:margin-left:0em;;;"><a href="I9_TIA.html">I9_TIA</a>: Transient ischemic attack (ICD-10: G45)<br></span>
<span style="margin-left:0em;"><a href="E4_LIPOPROT.html">[C] E4_LIPOPROT</a>: Disorders of lipoprotein metabolism and other lipidaemias (ICD-10: E78)<br></span>
<span style="margin-left:0em;"><a href="E4_AMYLOIDOSIS.html">[C] E4_AMYLOIDOSIS</a>: Amyloidosis (ICD-10: E85)<br></span>
<span style="margin-left:margin-left:0em;;"><a href="RA_CO_MORB.html">RA_CO_MORB</a>: Rheumatoid arthritis -related co-morbidities <br></span>
<span style="margin-left:margin-left:margin-left:0em;;;"><a href="C_LYMPHOMA.html">C_LYMPHOMA</a>: Lymphomas <br></span>
<span style="margin-left:margin-left:margin-left:margin-left:0em;;;;"><a href="C_HODGKIN_LYMPHOMA.html">C_HODGKIN_LYMPHOMA</a>: Hodgkin lymphoma <br></span>
<span style="margin-left:margin-left:margin-left:margin-left:margin-left:0em;;;;;"><a href="C_FOLLICULAR_LYMPHOMA.html">C_FOLLICULAR_LYMPHOMA</a>: Follicular lymphoma <br></span>
<span style="margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:0em;;;;;;"><a href="C_NONFOLLICULAR_LYMPHOMA.html">C_NONFOLLICULAR_LYMPHOMA</a>: Non-follicular lymphoma <br></span>
<span style="margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:0em;;;;;;;"><a href="C_TNK_LYMPHOMA.html">C_TNK_LYMPHOMA</a>: Mature T/NK-cell lymphomas <br></span>
<span style="margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:0em;;;;;;;;"><a href="C_NONHODGKIN_NAS.html">C_NONHODGKIN_NAS</a>: Other and unspecified types of non-Hodgkin lymphoma <br></span>
<span style="margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:0em;;;;;;;;;"><a href="C_OTHER_SPECIAL_TNK_LYMPHOMA.html">C_OTHER_SPECIAL_TNK_LYMPHOMA</a>: Other specified types of T/NK-cell lymphoma <br></span>
<span style="margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:0em;;;;;;;;;;"><a href="LUNG_CANCER_MESOT.html">LUNG_CANCER_MESOT</a>: Lung cancer and mesothelioma <br></span>
<span style="margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:0em;;;;;;;;;;;"><a href="C_PSOR_ARTHR_COMORB.html">C_PSOR_ARTHR_COMORB</a>: Psoriatic arthropathies related co-morbidities <br></span>
<span style="margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:0em;;;;;;;;;;;;"><a href="JUVEN_ARTHR_COMORB.html">JUVEN_ARTHR_COMORB</a>: Juvenile arthritis related co-morbidities <br></span>
<span style="margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:0em;;;;;;;;;;;;;"><a href="GOUT_COMORB.html">GOUT_COMORB</a>: Gout-related co-morbidities <br></span>
<span style="margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:0em;;;;;;;;;;;;;;"><a href="ARTHROSIS_COMORB.html">ARTHROSIS_COMORB</a>: Arthrosis related co-morbidities <br></span>
<span style="margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:0em;;;;;;;;;;;;;;;"><a href="SLE_COMORB.html">SLE_COMORB</a>: SLE-related co-morbidities <br></span>
<span style="margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:0em;;;;;;;;;;;;;;;;"><a href="SYSTINOTH_COMORB.html">SYSTINOTH_COMORB</a>: Systemic disorders of connective tissue in diseases classified elsewhere (FG) co-morbidities <br></span>
<span style="margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:0em;;;;;;;;;;;;;;;;;"><a href="SPONDYLOPATH_COMORB.html">SPONDYLOPATH_COMORB</a>: Spondylopathy related co-morbidities <br></span>
<span style="margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:margin-left:0em;;;;;;;;;;;;;;;;;;"><a href="FIBRO_COMORB.html">FIBRO_COMORB</a>: Fibromyalgia related co-morbidities <br></span>
<address><br>Created by: Aki Havulinna, Tuomo Kiiskinen on 2018-12-04 21:35:30</address>
 </body>
 </html>
